Age-related macular degeneration (AMD) is a multifactorial disease with a strong genetic basis. In recent years, the study of AMD genetics experienced a major advance; as a result, variants in more than 30 genes have been associated with AMD. It has been estimated that genetics contribute at least 40% of the risk associated with developing AMD.1-3 Most of this genetic risk is attributed to common single-nucleotide polymorphisms (SNPs) in the genes that encode CFH (HGNC 4883), ARMS2/HTRA1 (HGNC 32685/9476), and, to a lesser extent, CFB (HGNC 1037) and C3 (HGNC 1318); interestingly, the risk variants in the ARMS2 and HTRA1 genes are in nearly complete linkage disequilibrium. The remaining risk variants, including common (such as ones in VEGF [HGNC 12680] and CFI [HGNC 5394]) and rare variants (such as additional variants in CFI and CFH), have only a modest or minor contribution to the overall risk of developing AMD.1,2
Chowers I. Genetics and the Variable Phenotype of Age-Related Macular Degeneration. JAMA Ophthalmol. 2016;134(6):681–682. doi:10.1001/jamaophthalmol.2016.0550
Ophthalmology in JAMA: Read the Latest
Customize your JAMA Network experience by selecting one or more topics from the list below.